Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Inovação e propriedade intelectual · 24/02/20231 min de leitura
Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments" that was published in the Federal Register on November 7, 2022, until March 10, 2023.
Idioma original da fonte: Federal Register — Patent and Trademark OfficeAbrir o comunicado original →